Annovis Bio's CEO Maria Maccecchini Issues Letter to Stockholders

/PRNewswire/ -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company addressing neurodegenerative diseases,...

Related Keywords

Berwyn ,Pennsylvania ,United States ,Marial Maccecchini ,Maria Maccecchini ,Nic Johnson ,Annovis Bio ,Exchange Commission ,Prnewswire Annovis Bio Inc ,Linkedin ,Twitter ,Annovis Bio Inc ,Russo Partners ,Chief Executive Officer ,Fellow Stockholder ,Down Syndrome ,Executive Board ,Annual Report ,Investor Contact ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,